Storia in 2 fonti

West Reports Second-Quarter 2026 Results

Raccontata da

morningstar.com

benzinga.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

morningstar.comStai leggendo1 mese fa

West Reports Second-Quarter 2026 Results

West Pharmaceutical Services reported second-quarter 2026 net sales of $872.3 million, up 12.7% organically, driven by high-value product components and GLP-1 elastomer strength. The biologics and GLP-1 sector expansion signals robust pharma supply-chain consolidation, relevant for tech leaders assessing medtech partnerships and enterprise software positioning.

originale

benzinga.com1 mese fa

West Pharmaceutical CEO Highlights GLP-1 And Biologics Momentum - West Pharmaceutical Servs (NYSE:WST)

West Pharmaceutical reported Q2 earnings and revenue beat, higher 2026 guidance, and continued strength in GLP-1 and HVP products.

Leggi questa versione →

Timeline cronologica

martedì 21 luglio 2026·morningstar.com
East West Bancorp Reports Second Quarter 2026 Results, With Earnings Per Share Up 18% Year-Over-Year, Driven by Record Total Revenue
East West Bancorp Reports Second Quarter 2026 Results, With Earnings Per Share Up 18% Year-Over-Year, Driven by Record Total Revenue
mercoledì 22 luglio 2026·morningstar.com
WEX Inc. Reports Second Quarter 2026 Financial Results
WEX Inc. Reports Second Quarter 2026 Financial Results

West Reports Second-Quarter 2026 Results

West Pharmaceutical CEO Highlights GLP-1 And Biologics Momentum - West Pharmaceutical Servs (NYSE:WST)

Timeline cronologica

East West Bancorp Reports Second Quarter 2026 Results, With Earnings Per Share Up 18% Year-Over-Year, Driven by Record Total Revenue

WEX Inc. Reports Second Quarter 2026 Financial Results

West Reports Second-Quarter 2026 Results

West Pharmaceutical CEO Highlights GLP-1 And Biologics Momentum - West Pharmaceutical Servs (NYSE:WST)